NEW YORK (GenomeWeb) – Co-diagnostics today announced an agreement to allow Biosearch Technologies to make and use the firm's CoPrimers technology, as well as market and sell it to research institutions.

Under the terms of the agreement, Sandy, Utah-based Co-Diagnostics will also grant Biosearch a license to use CoPrimers in the firm's own research and development. Biosearch has also agreed to help customers find the optimal primer sets for a given research application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.